blood diseases

Hemab raises $157M series C for rare bleeding disorder goals

The company will use the funding to build out its pipeline to advance its clinical candidates for Glanzmann thrombasthenia and von Willebrand disease.

Zoey Becker Oct 27, 2025 6:00am

Vertex and Orna team up to develop new blood disorder treatments

Jan 7, 2025 7:00am

ASH surveys identify barriers to improving diversity in research

Dec 16, 2024 5:10pm

Sanofi BTK inhibitor for blood disease raises platelet levels

Nov 5, 2024 1:42pm

Silence breaks down phase 1 data on blood disorder prospect

Jun 27, 2024 9:40am

Graphic of a drop of blood made up of small data points and nodes

Takeda's anti-CD38 antibody boosts platelet count in phase 2

Jun 24, 2024 8:58am